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Abstract
Amyloid beta (Ab) peptide accumulation in the brains of patients with Alzheimer’s disease (AD) is closely associated with
increased nerve cell death. However, many cells survive and it is important to understand the mechanisms involved in this
survival response. Recent studies have shown that an anti-apoptotic mechanism in cancer cells is mediated by aerobic
glycolysis, also known as the Warburg effect. One of the major regulators of aerobic glycolysis is pyruvate dehydrogenase
kinase (PDK), an enzyme which represses mitochondrial respiration and forces the cell to rely heavily on glycolysis, even in
the presence of oxygen. Recent neuroimaging studies have shown that the spatial distribution of aerobic glycolysis in the
brains of AD patients strongly correlates with Ab deposition. Interestingly, clonal nerve cell lines selected for resistance to
Ab exhibit increased glycolysis as a result of activation of the transcription factor hypoxia inducible factor 1. Here we show
that Ab resistant nerve cell lines upregulate Warburg effect enzymes in a manner reminiscent of cancer cells. In particular,
Ab resistant nerve cell lines showed elevated PDK1 expression in addition to an increase in lactate dehydrogenase A (LDHA)
activity and lactate production when compared to control cells. In addition, mitochondrial derived reactive oxygen species
(ROS) were markedly diminished in resistant but not sensitive cells. Chemically or genetically inhibiting LDHA or PDK1 re-
sensitized resistant cells to Ab toxicity. These findings suggest that the Warburg effect may contribute to apoptotic-
resistance mechanisms in the surviving neurons of the AD brain. Loss of the adaptive advantage afforded by aerobic
glycolysis may exacerbate the pathophysiological processes associated with AD.
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Introduction
Alzheimer’s disease (AD) is a complex neurodegenerative
condition, and is the most common form of dementia among
the elderly. Currently, there is no cure for the disease and
treatment options remain limited. AD is characterized at the
histopathological level by widespread nerve cell death, synaptic
loss and the accumulation of intracellular neurofibrillary tangles
(NFT) and extracellular plaques within the brain [1]. These
plaques are primarily composed of amyloid b-peptide (Ab), a 40–
42 amino acid peptide derived from the proteolytic cleavage of the
amyloid precursor protein (APP) [2,3,4]. A prevalent theory in the
field is that AD is caused primarily by Ab deposition within the
brain, which leads to an increased production of reactive oxygen
species (ROS), oxidative damage, mitochondrial dysfunction and
cell death [5,6,7,8,9]. Interestingly, some populations of cells
within the brain survive by becoming resistant to Ab toxicity.
Immunohistochemical analysis of brain tissue from individuals that
died without any history of dementia has revealed that up to 40%
of the autopsied samples had significant plaque accumulation
[10,11]. While difficult to study in vivo, it is possible to examine
amyloid resistance in cultured nerve cells. Clonal nerve cell lines
selected for resistance to Ab toxicity exhibit increased resistance to
a wide array of neurotoxins including glutamate, hydrogen
peroxide and rotenone, suggesting that these cells have acquired
a common resistance mechanism to survive exposure to environ-
mental stresses [7,12,13]. Initial studies revealed that Ab-resistant
cells upregulate several antioxidant and glycolytic enzymes
[12,14,15]. However, further investigation into these survival
mechanisms is necessary for a greater understanding of Ab-
sensitivity and resistance.
Aerobic glycolysis (the Warburg effect) in cancer
In normal nerve cells glucose is converted to pyruvate through a
number of steps within the cytosol. In the presence of oxygen,
pyruvate is converted into acetyl-Coenzyme A (acetyl-CoA), by
pyruvate dehydrogenase (PDH) within the mitochondria. Acetyl-
CoA is subsequently fed into the tricarboxcylic acid cycle (TCA
cycle), ultimately producing energy via oxidative phosphorylation.
In an environment lacking oxygen cells must depend on glycolysis
whereby pyruvate is converted into lactate by lactate dehydroge-
nase subunit A (LDHA), resulting in increased lactate production.
Hypoxia inducible factor 1 (HIF-1), a transcription factor induced
in hypoxic microenvironments, mediates the critical cellular
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glycolytic genes including ldha [16,17]. In addition to mediating
the increased conversion of pyruvate to lactate, HIF-1 has recently
been shown to actively suppress mitochondrial respiration by
directly upregulating the expression of the gene encoding pyruvate
dehydrogenase kinase 1 (PDK1) [18,19]. PDK1 phosphorylates
and inhibits PDH, thereby acting as a molecular switch between
glycolysis and aerobic respiration to meet cellular ATP needs.
Initially HIF-1 was believed to be a transcription factor involved in
mediating the cellular metabolic adaptation to hypoxia, however it
has more recently been shown to be active in normoxic conditions,
such as vascularised cancer tissues, suggesting an addition role for
the transcription factor [20,21].
Enhanced glycolysis and increased lactate production is a
common property of invasive cancers and its upregulation in cancer
may result in the suppression of apoptosis [22,23]. The initial
upregulation of glycolysis in tumors is believed to be triggered by a
hypoxic microenvironment and HIF-1 activity. However, despite
increasing oxygen availability the glycolytic phenotype persists
[21,24]. This phenomenon has been termed the Warburg effect or
aerobic glycolysis [22,25]. In addition to upregulation of glycolysis,
cancer cells decrease the flux of pyruvate through the mitochondria
via upregulation of PDK, and the inhibition of PDH [22,26,27].
This shift in metabolism causes a drop in both mitochondrial
oxygen consumption and associated ROS production [22].
Therefore, lower levels of mitochondrial activity lead to a decrease
in both ROS production and the propensity of mitochondria to
depolarize; two events that trigger apoptosis. The Warburg effect is
believed to provide a selective advantage for the survival and
proliferation of tumorigenic cells however it has rarely been
examined in other cellular contexts [22,23].
Aerobic glycolysis in AD
Recent studies using PET imaging revealed a strong spatial
correlation between aerobic glycolysis and Ab deposition in the
brains of AD patients [28]. Additionally, activities of the glycolytic
enzymes pyruvate kinase (PK), and lactate dehydrogenase A
(LDHA), are elevated in the frontal and temporal cortex of
patients with AD [29]. In contrast, the reductions of various
mitochondrial enzymes involved in cellular respiration have been
reported in the AD brain [30,31,32]. Interestingly, Ab-resistant
nerve cells in vitro exhibit increased glucose uptake and flux
through the glycolytic pathway [14]. Ab-resistant cells are also
highly sensitive to glucose deprivation suggesting that the altered
glycolytic metabolism in these cells may mediate Ab resistance.
However, it is unknown if Ab resistant cells repress mitochondrial
respiration and rely primarily on glycolysis for their energy needs.
Evidence to suggest a Warburg effect may exist in AD is
supported by the observation that elevated levels of HIF-1a are
detected in cultured Ab resistant cells and in the brains of AD
transgenic mice compared to controls [14]. Additionally, stabili-
zation of HIF-1a and an increase in HIF-1 activity protects
cortical neurons from Ab toxicity [14]. Potentially, HIF-1 may act
in a manner similar to cancer cells by upregulating LDHA and
PDK in Ab resistant cells and surviving neurons of the AD brain.
Elevated mitochondrial-derived ROS is strongly linked to Ab
induced death [6,7,12]. The impairment of mitochondrial
metabolism in AD has been well documented and it is possible
that a decrease in the flux of pyruvate through the mitochondria in
Ab resistant cells results in decreased mitochondrial respiration
and ROS production similar to cancer cells [22,33,34]. An
increased reliance on glycolysis for production of ATP may give
surviving cells an advantage in the hostile environment of the AD
brain. Additionally, decreased mitochondrial activity may atten-
uate the release of apoptogenic factors [22,35]. Taken together,
the increase in glycolysis and lactate production and/or repression
of mitochondrial activity may play a role in the protection of
neurons against Ab toxicity in AD, although this hypothesis has
never formally been examined.
To investigate if a Warburg effect exists in Ab resistant cells, and
if this contributes to their resistance against Ab toxicity, two nerve
like cell lines, PC12 and B12, and their Ab resistant derivatives
were selected and characterized. Here we show that nerve cell
lines which are resistant to Ab, break down glucose in a manner
reminiscent of cancer cells. Western blot analysis revealed
increased levels of PDK1 in Ab resistant cells exposed to Ab
compared to parental sensitive cells. Ab resistant cells showed
higher levels of LDHA activity and also generated higher levels of
lactic acid compared to sensitive cells. Chemical and genetic
inactivation of either LDHA or PDK1 promoted increased cell
death in Ab-resistant cells following Ab exposure. These findings
indicate that a shift in metabolism to rely heavily on glycolysis for
energy needs, may provide nerve cells with a mechanism to survive
Ab accumulation within the AD brain.
Methods
Materials
Cell culture reagents including Dulbecco’s modified Eagles
medium (DMEM), penicillin/streptomycin P/S, DMEM without
phenol red and Dulbecco’s phosphate buffered saline (DPBS, 1X)
were purchased from Biowhittaker (Walkersville, MD, USA).
Dialyzed fetal bovine serum (FBS) and horse serum (HS) were
obtained from PAA Laboratories Inc. (Etobicoke, ON, Canada).
OPTIMEM I (1X) and TrypLE Express (1x) were obtained from
Invitrogen (Carlsbad, CA, USA). Amyloid beta (Ab) peptide (25–
35) was purchased from California peptide research (San
Francisco, CA, USA). Poly-D-lysine, L-Lactic dehydrogenase
solution Type II, L(+)-lactic acid,98%, b-Nicotinamide adenine
dinucleotide (NAD
+), b-Nicotinamide adenine dinucleotide re-
duced disodium salt (NADH), sodium pyruvate, potassium
hydroxide, perchloric acid, sodium oxamate, dichloroacetic acid
(DCA) $99%, Bisbenzimide (Hoechst), Poly-D-lysine, puromycin,
dimethyl formamide, 3-(4,5-dimethlythiazol-2-yl)-2,5-diphenyl tet-
razolium bromide (MTT) were all purchased from Sigma (St.
Louis, MO, USA). G418 sulfate was purchased from Calbiochem
(EMD Chemicals Inc., Darmstadt, Germany). Mitotracker Red
CM-H2XRos (Molecular Probes) was purchased from Invitrogen
(Carlsbad, CA, USA).
Cell culture
The PC12 and B12 immortalized nerve cell lines and their Ab
resistant derivatives were obtained from Dr. David Schubert (The
Salk Institute, La Jolla, CA) and cultured as previously described
[7,12]. The PC12 cell lines used in this study are a subclone of a
cell line originally derived from a rat pheochromocytoma [36] and
were grown in DMEM supplemented with 10% fetal bovine
serum, 5% horse serum, and 1% penicillin/streptomycin. The B12
central nervous system cells are an immortalized clonal cell line
derived from a nitrosoethylurea induced brain tumor in rats [37]
and were grown in DMEM supplemented with 10% FBS, and 1%
P/S. The PC12 and B12 Ab resistant cell lines were isolated
following 4 months growth in the presence of Ab and subsequent
cloning [7,12]. Prior to experimentation the Ab resistant clones
were re-selected in 20 mMA b (25–35) for two weeks. The Ab
peptide (25–35) was dissolved in water at 1 mg/ml, left overnight
at room temperature to promote fibril formation and subsequently
stored at 220uC.
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The activity of LDHA was determined spectrophotometrically.
PC12 and B12 cells were plated at an appropriate density to
achieve 70–80% confluency before exposure to Ab25–35 (20 mM).
Ab-treated and untreated PC12 and B12 cells were washed twice
in DPBS and harvested in lysis buffer (50 mM Tris pH 7.5, 2%
SDS and 1 mM PMSF) at 24 hr and 48 hr. Following a freeze/
thaw cycle, protein extracts were quantified by a Lowry Assay
(Bio-Rad, Richmond, CA, USA). LDHA catalyzes the reversible
reduction of pyruvate to lactate, using NADH as a co-substrate.
The activity of LDHA in each sample was determined by
measuring the change in absorbance as a result of the oxidation of
NADH at a wavelength of 340 nm (37uC) as previously described
[38] and standardized to overall protein concentration.
Lactate assay
Lactate levels in the extracellular fluid of Ab treated and
untreated PC12 and B12 parental and resistant lines were
measured spectrophotometrically [39]. PC12 and B12 cells were
plated on 35 mm dishes at an appropriate density to achieve 70–
80% confluency following an overnight incubation. One day after
seeding the media was aspirated, the cells were washed with DPBS
and the media was replaced with OPTIMEM I media. Ab25–35
20 mM) was also added to the test dishes immediately after
changing the media to OPTIMEM I. Following 24 hr and 48 hr
incubation lactate released into the medium was measured. One
tenth volume of 70% perchloric acid (PCA) was added to the
harvested media, and samples were put on ice for 10 minutes.
Precipitated proteins were removed by centrifugation, and the
acidified supernatant was neutralized by adding the appropriate
amount of 10 M KOH to achieve pH 7.5. Lactate levels in the
samples were measured spectrophotometrically as described
previously [39] and absolute amounts were determined by
comparison to a lactate standard curve.
Immunoblot Analysis
To assess absolute level of LDHA and PDK1, treated (20 mM
Ab25–35) and untreated PC12 and B12 cells from subconfluent
cultures were washed twice in cold DPBS and harvested in a Tris
extraction buffer (50 mM Tris pH 7.5, 2% SDS and 1 mM
PMSF) at 24 hr and 48 hr. Protein extracts were quantified by a
Lowry assay, resolved by 12% SDS PAGE and electroblotted onto
PVDF membrane (Bio-Rad Richmond, CA, USA) [15]. Mem-
branes were probed with the following antibodies: polyclonal anti-
LDHA (1:1000; Cell Signaling, Danvers, MA, USA), polyclonal
anti-PDK1 (1:1000; Stressgen, San Diego, CA, USA) and a
monoclonal anti-b-actin (1:2000; Cell Signaling, Danvers, MA,
USA) followed by incubation with an appropriate horseradish
peroxidase (HRP) -conjugated secondary antibody (Bio-Rad,
Richmond, CA, USA). The blots were developed using Pierce
ECL western blotting substrate (Thermo Scientific, Rockford, IL,
USA) and visualized with a Bio-Rad Molecular Imager (Chemi-
Doc XRS, Bio-Rad, Richmond, CA, USA). Densitometric
analysis was performed using Image J software. Band densities
were standardized against b-actin, and the ratio of LDHA/PDK1-
specific bands relative to the b-actin band was determined.
Relative intensity was calculated by comparing the LDHA/or
PDK1/b-actin ratio of the resistant lines to the same ratio in the
parental cell line.
Cytotoxicity assay
Ab induced cell cytotoxicity (cell viability) was assessed by a
modified MTT assay [7,12,40]. The MTT assay measures the
reduction of the tetrazolium salt MTT to a colored formazan in
living cells [7,12]. Cells were seeded (3 610
3cells/well) in a 96
well microtiter plate and, following overnight incubation, Ab25–35
was added to the test wells at a concentration of 20 mM.
Neutralized DCA (2.5 mM), an inhibitor of PDK1, or oxamate
(20 mM), an inhibitor of LDHA, were also added to the
appropriate test wells. Following 48 hr incubation 10 ml of MTT
stock (2.5 mg/ml dissolved in DPBS) was added to each well, and
plates were incubated again, for 4 hours, then 100 mlo f
solubilization solution (20% SDS in 50% dimethyl formamide
pH 4.8) was added to each well and plates were rocked at room
temperature overnight. The following day plates were read on a
microplate reader (BioRad Model 3550) using 595 nm as the test
wavelength and 655 nm as the reference wavelength. The percent
viability was calculated from the mean absorbance of the treated
cells divided by the mean absorbance of the control cells and
multiplied by 100%. Ab induced cytotoxicity was also assessed by
a trypan blue exclusion assay. Cells were seeded in 12-well dishes
and following overnight incubation Ab25–35 was added to the test
wells at a concentration of 20 mM. Neutralized DCA (2.5 mM) or
oxamate (20 mM) were also added to the appropriate test wells.
Following a 48 hr incubation cells were trypsinized, pelleted and
resuspended in 200 ml of culture media to which an equal volume
of trypan blue was added. Cells excluding typan blue were scored
in triplicate using a haemocytometer and a light microscope. Prior
to experimentation oxamate and DCA were both tested for
toxicity at a range of treatment concentrations. For each inhibitor,
a treatment concentration was selected that conferred little to no
toxicity in cells (20 mM oxamate, 2.5 mM DCA).
Fluorescence microscopy
Mitochondrial ROS production was visualized by the fluores-
cent dye Mitotracker Red CM-H2XRos (MTR). Stock MTR was
dissolved in dimethylsulfoxide (DMSO) at a concentration of
1 mM and stored at 220uC. PC12 and B12 cells were plated
(8610
4) in 6 well glass bottom tissue culture dishes pretreated with
polylysine (50 mg/ml for 3 hr) and incubated overnight. PC12
parental cells were plated at a higher density of 3610
5 cells/well.
The following day cells were treated with 20 mMA b25–35 for
48 hr. Following treatment with Ab, the media was aspirated and
new media was added containing MTR at a concentration of
100 nM. Plates were then incubated at 37uC for 20 min, washed
in DPBS containing Hoecsht stain (10 mg/ml), followed by an
additional wash in DPBS and then placed in phenol red free
DMEM. Cells were visualized by fluorescence microscopy (Zeiss-
AxioObserver, 40X objective) and pictures were taken using a Q
Imaging (Retiga 1300 monochrome 10-bit) camera and Q
Capture software. Pictures were taken of three random fields of
view for each experiment. MTR fluorescence was quantified with
ImageJ software.
Derivation of PDK1 and LDHA knockdown cell lines
One resistant clone from each cell line, R7 (PC12) and R2 (B12)
were selected to make stable knock down lines. All cells were
transfected with lipofectamine (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s directions. Cells were plated at a
density to achieve 70–80% confluency. Cells were transfected with
HuSH 29mer shRNA (Origene, Rockville, MD, USA) constructs
directed at rat Ldha or rat Pdk1. The shRNA vector is cloned in the
pRS plasmid under the control of the U6 promoter for
mammalian cell expression. For each specific mRNA, 2 shRNA’s
containing expression cassettes, targeted at different parts of the
mRNA were selected. The selected shRNA constructs directed
against Ldha were: 71-TGGAATCTCAGATGTTGTGAAGGT-
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GAC); the shRNA constructs directed against Pdk1 were: 29-
AATCACCAGGACAGCCAATACAAGTGGTT and 30-TCG-
GTTCTACATGAGTCGCATC-TCAATTA). A non effective
shRNA construct (scrambled) in pRS plasmid was selected as a
negative control. Each shRNA construct for both Ldha and Pdk1 in
addition to the scrambled construct (5 total) were separately
transfected and selected for their resistance to 1 mg/ml puromycin.
Approximately 10–12 clones were picked, expanded and screened
by western blot analysis for successful knockdown.
Statistical Analysis
Data are presented as means 6 SD resulting from a least three
independent experiments. Data were analyzed statistically using a
one-way ANOVA followed by a Tukey test (VassarStats). Results
were considered statistically significant at P,0.05.
Results
Increased LDHA activity and lactate production in
Ab-resistant cells
LDHA is responsible for the conversion of pyruvate to lactate
and the increased activity of this enzyme in cancer cells is strongly
associated with the Warburg effect [41,42,43]. To determine if a
similar effect is observed in Ab-resistant cells, we measured LDHA
activity and secreted lactate levels in both Ab-sensitive PC12 and
B12 parental cells and clonal lines that have been selected for
resistance to Ab. Interestingly, all the resistant lines displayed
significantly higher levels of LDHA activity as compared to their
parental counterparts, with or without exposure to Ab (Fig. 1 A, B,
P,0.01). Additionally, the activity of LDHA in both parental lines
decreased with increased exposure to Ab. However, the activity of
LDHA in the PC12 resistant lines, R1 and R7, appeared to
decrease only slightly with exposure to Ab, but remained
significantly greater than the parental line for all treatments
(P,0.01). Similarly, the activity of LDHA in the B12 resistant
lines, R2 and R4, remained significantly greater than the parental
line with or without exposure to Ab (P,0.01). As a control, PC12
and B12 parental cells were exposed to hypoxic conditions (1%
O2) for 24 hr, as hypoxia is a known activator of LDHA [16],
revealing that both lines exhibited increased LDHA activity when
exposed to hypoxic conditions. We also examined LDHA protein
levels by western blot analysis using an LDHA-specific antibody.
However, there was no clear trend in LDHA expression between
both PC12 and B12 parental and resistant lines (data not shown).
LDHA activity has been shown to be regulated by both allosteric
effects and post translational modifications [44,45,46,47], there-
fore the increased activity we observed in Ab resistant cells may be
attributed to these modifications.
LDHA catalyzes the conversion of pyruvate to lactate which is
then released to the extracellular space by the monocarboxylate
transporters (MCT). To determine if the elevated LDHA in Ab
resistant cells was associated with increased lactate production, the
concentration of lactate in the extracellular media of cultured B12
and PC12 cells was examined. A significant increase in the
concentration of lactate was detected in the extracellular media of
PC12 and B12 resistant lines when compared to their respective
parental lines at 24 hr and 48 hr, with or without exposure to Ab
(20 mM) (Fig. 1 C, D, P,0.01). The concentration of lactate in
both PC12 and B12 parental lines decreased with exposure to Ab
whereas the concentration of lactate was maintained or increased
in all the resistant lines when exposed to Ab for 24 or 48 hrs.
These findings indicated that increased LDHA activity and
associated lactate production is strongly associated with Ab-
resistance.
PDK1 levels are elevated in Ab-resistant cells
Elevated PDK1 expression in cancer cells has been shown to
result in reduced mitochondrial respiration and resistance to
apoptosis [22]. To determine if elevated PDK1 expression
contributes to resistance to Ab toxicity, cell extracts from sensitive
and resistance cells were analyzed by Western blot analysis. Highly
elevated PDK1 levels were detected in all Ab-resistant lines
relative to parental cell lines in either the presence of absence of
Ab (Fig. 2). Interestingly, an additional band around 30 kDa was
detected that was more prominent than full length PDK1
(,48 kDa) in B12 cells. This lower molecular weight band also
showed the same elevated trend as full length PDK1 in the R2 and
R4 lines (Fig. 2 B). The lower molecular weight PDK1 band may
represent some form of cleavage product/posttranslational
modification of PDK1. In contrast, the PC12 and B12 parental
cell lines exhibited a 14% and 39.5% reduction in PDK1 levels
respectively following 48 hr exposure to Ab. Thus, increased
PDK1 expression strongly correlates with Ab resistance.
Mitochondrial ROS production is decreased in
Ab-resistant cells
A decrease in mitochondrial-derived ROS is a key feature of the
Warburg effect and plays a prominent role in resistance to
apoptosis [22]. We therefore examined mitochondrial ROS in Ab
sensitive and resistant cells using Mitotracker ROS Red (MTR); a
dye that specifically incorporates in mitochondria and only
fluoresces in the presence of ROS [22]. A significant decrease in
mitochondrial ROS, as measured by mean MTR fluorescence,
was observed in PC12 and B12 resistant cells compared to their
parental counterparts with or without exposure to Ab (20 mM)
(Fig. 3 A, B, P,0.01). In contrast, there was a pronounced
increase in mitochondrial ROS in both PC12 and B12 parental
lines following 48 hr exposure to Ab (P,0.05). Thus Ab-resistant
cells appear to have an altered metabolism resulting in significantly
less mitochondrial-derived ROS under both basal and stressed
conditions.
Chemical inhibition of LDHA or PDK1 restores sensitivity
to Ab in resistant cells
Inhibition of LDHA or PDK1 using the chemical inhibitors
oxamate and dichloroacetate (DCA) respectively, has been shown
to counter the Warburg effect and apoptosis resistance in cancer
cells [22,27,48]. When the PC12 and B12 resistant cell lines were
treated with either chemical inhibitor, oxamate (20 mM) or DCA
(2.5 mM), and Ab (20 mM) there was a significant decrease in cell
viability when compared to Ab treatment alone (Fig. 4 A–D,
P,0.01). Interestingly, exposure of the PC12 and B12 parental
lines to either oxamate or DCA did not appear to potentiate Ab
toxicity. To ensure that oxamate and DCA did not interfere with
the reduction of MTT and subsequent formazan formation, these
experiments were repeated using a trypan-blue exclusion viability
assay and similar results were observed (Figure S1). These findings
indicate that chemical inhibition of either LDHA or PDK1 can
resensitize Ab-resistant cells to Ab.
Attenuated LDHA and PDK1 expression reverses Ab
resistance
Because chemical inhibitors such as oxamate and DCA could
potentially have off-target effects, we sought to determine if
specific inhibition of LDHA and PDK1 expression by shRNA –
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Ab. Immunoblot analysis confirmed that PC12 R7 and B12 R2
cell lines stably transfected with shRNA vectors containing
sequences directed at rat Ldha or Pdk1 transcripts exhibited
decreased expression of the targeted mRNAs compared to cells
transfected with a control shRNA containing a non-specific/
scrambled (scram) sequence (Fig. 5). Densitometric analysis
revealed there was a 52% and 62% reduction in LDHA levels
in the R7 knockdown lines 71-7 and 72-11 respectively, and a 65%
and 72% reduction in PDK1 levels in the R7 knockdown lines 29-
11 and 30-10 respectively when compared to the R7 control line
scram-10 (Fig. 5 A, B). By knocking down either LDHA or PDK1
expression in the R7 Ab resistant cell line, we observed a
significant decrease in cell viability, following exposure to 48 hr
Ab (20 mM) when compared to the control (Fig. 5 C, P,0.01).
Reduction of LDHA or PDK1 expression in R7 cells resulted in a
40 to 50% reduction in viability compared to the control cell lines.
(Fig. 5 C).
Western blot analysis revealed there was a 50% and 62%
reduction in LDHA levels in the R2 knockdown lines 71-23 and
72-5 respectively, and a 48% and 49% reduction in PDK1 levels
in the R2 knockdown lines 29-12 and 30-4 respectively, when
compared to R2 line scram 5 (Fig. 5 D, E). Exposure of the R2
LDHA or PDK1 knockdown clones to 48 hr Ab (20 mM) resulted
in a significant reduction in cell viability (between 43 to 52%)
when compared to the control (Fig.5 F, P,0.01). Thus, specifically
Figure 1. LDHA activity and lactate levels are elevated in Ab-resistant cells. A) LDHA activity was significantly greater in PC12 Ab resistant
cells lines, R1 and R7, as compared to the parental line both in the absence and presence of Ab (*, P,0.01). As a control, PC12 parental cells exposed
to 24 hr hypoxia (1%O2) also exhibited significantly greater LDHA activity when compared to untreated parental cells (*, P,0.01). B) LDHA activity
was also significantly greater in B12 Ab resistant cells lines, R2 and R4, as compared to the parental line under the same conditions (* P,0.01). B12
parental cells exposed to 24 hr hypoxia (1%O2) also exhibited greater LDHA activity when compared to untreated parental cells (*, P,0.01). (C)
Extracellular lactate was significantly elevated in PC12 Ab-resistant lines, R1 and R7 and (D) B12 Ab resistant lines, R2 and R4, when compared to their
respective parental cells cultured under similar conditions (*; P,0.01). Data represent the average 6 SD of three independent experiments. Data was
analyzed by a one-way ANOVA followed by a Tukey test.
doi:10.1371/journal.pone.0019191.g001
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results in re-sensitization to Ab and increased death.
Discussion
Understanding how nerve cells become resistant to Ab toxicity
is central to understanding how some nerve cells within the AD
brain are able to survive while large numbers of cells die. It had
been previously shown that Ab resistant cells, through increased
HIF-1 activity, modulate their cell metabolism to increase glucose
uptake and glycolysis in the presence of Ab [14]. Additionally,
HIF-1 activation in Ab sensitive cells is sufficient for neuropro-
tection against Ab [14]. However, this earlier study did not
precisely define how HIF-1 functions to protect cells from Ab
toxicity. One compelling idea is that HIF-1 driven alteration in
metabolism in Ab resistant cells confers a selective advantage for
survival in the hostile environment of the AD brain [14,49].
Increased HIF-1 activity has been shown to enhance transcription
of both LDHA and PDK1 [16,18]. In this study we observed that
Ab resistant cells have increased LDHA activity and PDK1
expression, both in the absence or presence of Ab, and these
events correlate with decreased mitochondrial derived ROS.
The question arises as to why decreased mitochondrial
respiration in Ab resistant cells would be advantageous? A
previous study showed that cells depleted of mitochondrial
DNA, lacking critical catalytic subunits of the respiratory chain
and incapable of mitochondrial respiration, were unaffected by Ab
exposure [50]. Mitochondria are the major site of ROS
production, which is believed to be a major factor leading to Ab
induced death [7]. This is supported by the observation that
exogenously applied antioxidants protect primary CNS cultures
and clonal lines from Ab toxicity [7]. In addition, overexpression
of the mitochondrial antioxidant enzyme manganese superoxide
dismutase (MnSOD) in AD transgenic mice increases resistance to
Ab and attenuates the AD phenotype [51]. These studies suggest
that functional mitochondria are required for Ab to elicit a toxic
effect.
In support of these findings, the data in this study reveal that Ab
resistant nerve cell lines exhibit metabolic reprogramming and
decreased mitochondrial ROS which contribute to their resistance
against Ab toxicity. Interestingly, these low levels of ROS were
maintained even after exposure to Ab. In contrast, the parental
sensitive lines showed elevated mitochondrial ROS with exposure
to Ab. The increase in LDHA activity, lactate production and
PDK1 levels, and decrease in mitochondrial ROS strongly
indicate that a Warburg effect exists in Ab resistant cells.
Interestingly chemical or genetic manipulation of either LDHA
or PDK1 resulted in increased sensitivity to Ab in all resistant cell
Figure 2. PDK1 is upregulated in Ab resistant cells. A) PDK1 levels were significantly elevated in both PC12 resistant lines, R1 and R7, when
compared to the parental cell line (*,P,0.01). These elevated levels were maintained following 24 and 48 hr Ab treatment (* 20 mM). B) PDK1 levels
were also significantly greater in both B12 resistant lines, R2 and R4, when compared to the parental line (*,P,0.01; **,P,0.05). These increased levels
were also maintained with Ab treatment. An additional band of approximately 30 kDa that was more prominent than full length PDK1 (,48 kDa). This
additional band also showed the same elevated trend as full length PDK1 in the R2 and R4 lines when compared to the parental under similar
conditions. The smaller band may represent a cleavage product of PDK1. Densitometric analysis of PDK1 band densities relative to actin are found in
the lower panel. Relative intensity was calculated by comparing the PDK1/actin ratio of the resistant lines to the same ratio in the parental cell line.
Data represent the average 6 SD of three independent experiments.
doi:10.1371/journal.pone.0019191.g002
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PDK1, contribute to resistance to Ab. However, inhibiting or
knocking down either enzyme resulted in similar levels of
sensitivity to Ab suggesting that both enzymes appear to play an
equal and possibly redundant role in the resistance pathway.
Knocking down or chemically inhibiting LDHA or PDK in
various cancers shifts metabolism from glycolysis and lactate
production to mitochondrial respiration, with an associated
increase in mitochondrial ROS production and induction of
apoptosis [22,27,42,43]. Furthermore, inhibition of PDK1 in
cancer cells in vitro and in vivo results in a reduction of
phosphorylated PDH and HIF-1a levels [52]. Moreover, inhibi-
tion of PDK1 expression has been shown to decrease lactate levels
and HIF-1a expression and reduce the malignant phenotype of
cancer cells [52]. Therefore an increase in PDK1 and lactate
production may aid in sustaining the Warburg effect through a
Figure 3. Decreased mitochondrial reactive oxygen species in Ab resistant cells. A) PC12 Ab resistant lines R1 and R7 exhibited a significant
reduction in mitochondrial reactive oxygen species (ROS) compared to the parental cell line under normal culture conditions (*, P,0.01). This
decrease in ROS was maintained with 48 hr Ab (20 mM) exposure. Conversely, mitochondrial ROS significantly increased in the parental line when
exposed to Ab (**, P,0.05). B) The B12 resistant lines, R2 and R4 also exhibited decreased mitochondrial ROS when compared to parental cells under
similar conditions (*, P,0.01). A similar increase in mitochondrial ROS in B12 parental cells was also observed following treatment with Ab for 48 hr
(**, P,0.05). Cells were stained with MitoTracker Red (100 nM) and nuclei were stained with Hoescht (10 mg/ml) and visualized by fluorescence
microscopy at 400X magnification and quantified with ImageJ software. Data represent the average 6 SD of three independent experiments. Data
was analyzed by a one-way ANOVA followed by a Tukey test.
doi:10.1371/journal.pone.0019191.g003
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the glycolytic genes, ldha and pdk1 functions to suppress apoptosis
in Ab resistant cells by decreasing mitochondrial respiration and
ROS production (Fig. 6).
In the past, aerobic glycolysis within the brain has been given
little attention, despite early observations suggesting that a basal
level of aerobic glycolysis occurs in specific areas of the brain
[53,54]. In a healthy adult, levels of aerobic glycolysis can range
from ,10–15% of the glucose utilized by the human brain
[53,54,55]. More recently, PET imaging revealed a significant
increase in aerobic glycolysis in specific areas of the brain [56].
Specifically, the levels of aerobic glycolysis are elevated in the
medial and lateral parietal and prefrontal cortices [56]. Recent
PET imaging studies, using a radiotracer with a high affinity to Ab
plaques, revealed a strong correlation between the spatial
distribution of aerobic glycolysis and Ab plaques in both patients
with AD, as well as cognitively normal patients with high levels of
Ab deposition but without clinical manifestation of the disease
Figure 4. Chemically inhibiting LDHA or PDK1 decreases cell viability in Ab resistant cells. A significant decrease in cell viability in both
PC12 (A) and B12 (B) resistant lines was observed after 48 hr concomitant exposure to Ab (20 mM) and 20 mM oxamate (ox), a chemical inhibitor of
LDHA (*P,0.01). Similarly, 48 hr Ab exposure significantly decreased cell viability in both PC12 (C) and B12 (D) resistant lines when cells were co-
treated with 2.5 mM dichloroacetate (DCA), a chemical inhibitor of PDK1 (*P,0.01). Interestingly, the cell viability of the parental lines does not
appear to decrease with treatment of either inhibitor and Ab. Cell viability was determined by the reduction of the tetrazolium salt MTT. Data are
representative of three separate experiments. Data was analyzed by a one-way ANOVA followed by a Tukey test.
doi:10.1371/journal.pone.0019191.g004
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increased aerobic glycolysis closely mirrors the distribution of
aerobic glycolysis in the normal healthy brain [28,56]. Thus one
could conclude that areas of increased aerobic glycolysis within the
brain are more susceptible to Ab accumulation. However, the
opposing viewpoint is that an increase in aerobic glycolysis is an
innate protective response that limits the toxicity of Ab. Areas
within the normal brain that show increased aerobic glycolysis
highly overlap with the ‘default mode network’- brain regions that
are most active when an individual is awake but not engaged in a
specific task [28,56]. We propose that these areas of the brain are
the most susceptible to insult in AD and thus exhibit a Warburg
effect as a protective mechanism or a built in resistance
mechanism that can be further activated in the presence of high
levels of Ab.
Although a Warburg effect aids in the survival against Ab
toxicity, it may have a few detrimental effects. First, a reliance on
glycolysis, an inefficient means of producing energy, increases the
demand for glucose in these cells. Thus a small decrease in glucose
availability may render these cells incapable of producing sufficient
energy to sustain their function and lead to cell death. Secondly,
an increase in lactate production may result in decreased
glutathione levels, the major antioxidant in the brain responsible
for detoxifying ROS [57]. Lactate has been shown to inhibit the
Figure 5. Attenuated LDHA or PDK1 expression increases sensitivity of resistant cell lines to Ab.A ) Immunoblot analysis of PC12 R7
resistant cells stably transfected with LDHA-specific shRNA vectors revealed two clonal cell lines (clones 71-7,72-11) exhibited a significant decrease in
LDHA protein levels when compared to an R7 cell line transfected with a non-specific shRNA (SCR) (*P,0.01). B) Immunoblot analysis also confirmed
a significant decrease in PDK1 protein in two PDK-1 shRNA stably transfected R7 cell lines, (clones 29-1 and 30-10) when compared to the control cell
line (*P,0.01). C) A significant decrease in the cell viability of the R7 clones with attenuated expression of either LDHA or PDK1 when exposed to Ab
(20 mM) for 48 hr when compared to the control (* P,0.01). D) Immunoblots of R2 cell lines (clones 71-23 and 72-5) confirming significantly
decreased LDHA expression when compared to a control cell line (SCR) (*P,0.01). E) R2 clonal cell lines, (clones 29-12 and 30-4) stably expressing
PDK-1 shRNA showed a significant decrease in the PDK1 full length protein (,48 kDa) as well as a decrease in the proposed PDK1 cleavage product
(,30 kDa) when compared to the control (*P,0.01). F) Both R2 LDHA and PDK1 knockdown cell lines exposed to 48 hr Ab (20 mM) treatment
showed a significant decrease in cell viability when compared to R2 control (* P,0.01). Densitometric analysis of LDHA and PDK1 band densities
relative to actin are found below the corresponding blot. Relative intensity was calculated by comparing the LDHA/actin or PDK1/actin ratio of the
resistant lines to the same ratio in the scrambled shRNA cell line. Data represent the average 6 SD of three independent experiments. Data was
analyzed by a one-way ANOVA followed by a Tukey test.
doi:10.1371/journal.pone.0019191.g005
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would likely result in a decrease in glutathione synthesis and levels,
which could result in a decreased tolerance to ROS [57]. Lastly,
HIF-1 mediated increase in glycolysis may result in an increase in
Ab production and deposition within the brain. HIF-1 has been
shown to transcriptionally regulate both the b-site APP cleaving
enzyme (b-secretase/BACE1) and an essential enzyme involved in
the presenilin/c-secretase complex anterior pharynx-defective 1A
(APH-1A)[58,59]. Hypoxia or overexpression of HIF-1a increases
the BACE1 mRNA and protein levels in mouse neuroblastoma
N2a cells [58]. Similarly, treatment of HeLa cells stably expressing
the human APP Swedish mutation with NiCl2 (a chemical mimic
of hypoxia) results in an increase in APH-1A mRNA and protein
expression accompanied by an increased secretion of Ab [59].
These findings have quelled enthusiasm for the treatment of AD
using metal chelators to enhance HIF1a activity. However, our
findings suggest that enhancement of PDK1 activity alone may
offer a better neuroprotective strategy as it is unlikely to affect APP
processing. Further studies will need to be conducted to examine
this hypothesis.
Conclusion
We have shown for the first time a Warburg effect exists in Ab
resistant nerve cell lines, and contributes to resistance against Ab
toxicity. These findings suggest that the Warburg effect may act as
a common resistance mechanism in a variety of cell types in
response to diverse environmental stresses. However the physio-
logical relevance of these findings in an in vivo AD model remains
unknown. This shift in cell metabolism to rely heavily on glycolysis
and lactate production for energy needs may provide nerve cells
with a mechanism to overcome the pro-oxidant conditions elicited
by Ab exposure. Chemical means of modulating this pathway may
be of therapeutic interest in the treatment of AD. Moreover,
characterization of the mechanisms by which glycolysis is
upregulated in Ab resistant cells could reveal possible targets for
drug therapy in the treatment of AD.
Supporting Information
Figure S1 Treatment with oxamate or DCA decreases
cell viability in Ab resistant cells. A significant decrease in
cell viability in both PC12 (A) and B12 (B) resistant lines was
observed after 48 hr concomitant exposure to Ab (20 mM) and
20 mM oxamate (ox), a chemical inhibitor of LDHA, or Ab
(20 mM) and 2.5 mM dichloroacetate (DCA), a chemical inhibitor
of PDK1 (*P,0.01; **P,0.05). Cell viability was determined by
trypan blue exclusion. Data are representative of three separate
experiments. Data was analyzed by a one-way ANOVA followed
by a Tukey test.
(TIF)
Figure 6. Proposed role of the Warburg effect in Ab resistant cells. The stabilization of hypoxia inducible factor 1 a (HIF1a) and subsequent
increased activity of HIF-1 in amyloid beta (Ab) resistant cells stimulates increased expression of glucose transporters (Glut1), and glycolytic enzymes
increasing the conversion of glucose to pyruvate. Additionally, HIF-1 promotes the reduction of pyruvate to lactate through the upregulation of
lactate dehydrogenase A (LDHA). HIF-1 also actively suppresses the production of acetyl CoA through the mitochondria via increased expression of
pyruvate dehydrogenase kinase 1 (PDK1), which phosphorylates and inhibits pyruvate dehydrogenase (PDH) resulting in decreased flux through the
tricarboxcylic acid (TCA) cycle and repressed oxidative phosphorylation (OXPHOS). The decrease in electron transport activity decreases the
generation of reactive oxygen species (ROS) in the mitochondria and renders cells more resistant to apoptosis in the presence of Ab.
doi:10.1371/journal.pone.0019191.g006
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